Skip to main content
. 2020 Jun;8(12):752. doi: 10.21037/atm-20-4072

Figure 5.

Figure 5

Tan-I combination with Paclitaxel inhibits tumor growth in vivo. (A) Tumors in the control group, Tan-I group, PTX group, and combination group were isolated and pictured after four weeks’ treatment. (B) Tumors’ weight was calculated in the control group, Tan-I group, PTX group, and combination group. Data are shown as mean ± SD. *, P<0.05 versus which Tan-I group or PTX group. (C) Caspase-3 protein expression in tumor tissues of the control group, Tan-I group, PTX group, and combination group was analyzed by immunohistochemistry (magnification, 200×). (D) Ki67 protein expression in tumor tissues of the control group, Tan-I group, PTX group, and combination group was analyzed by immunohistochemistry (magnification, 200×). (E) Apoptosis assay in tumor tissues of the control group, Tan-I group, PTX group, and combination group was analyzed by TUNEL staining (magnification, 200×).